Persistent accumulation of interferon-γ-producing CD8+CD56+ T cells in blood from patients with coronary artery disease

Atherosclerosis

Volumn 224, Issue 2, 2012, Pages 515-520

  Bergström, Ida ^a   Backteman, Karin ^a   Lundberg, Anna ^a   Ernerudh, Jan ^a   Jonasson, Lena ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Acute coronary syndrome; Coronary artery disease; Cytokines; Immune system; Leukocytes

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGING; ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA, STABLE; ANTIGENS, CD28; ANTIGENS, CD56; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; INTERLEUKIN-15; INTERLEUKIN-6; MALE; MIDDLE AGED; PHENOTYPE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84866536263     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.07.033     Document Type: Article

References (31)

1. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nature Immunology 2011, 12:204-212.
2. Frostegård J., Ulfgren A.-K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145:33-43.
3. Grivel J.-C., Ivanova O., Pinegina N., et al. Activation of T lymphocytes in atherosclerotic plaques. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2929-2937.
4. Caligiuri G., Liuzzo G., Biasucci L.M., Maseri A. Immune system activation follows inflammation in unstable angina: pathogenetic implications. Journal of The American College of Cardiology 1998, 32:1295-1304.
5. Methe H., Brunner S., Wiegand D., Nabauer M., Koglin J., Edelman E.R. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. Journal of The American College of Cardiology 2005, 45:1939-1945.
6. Pasqui A., Di Renzo M., Bova G., et al. Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clinical and Experimental Medicine 2006, 6:38-44.
7. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
8. Jonasson L., Linderfalk C., Olsson J., Wikby A., Olsson A.G. Systemic T-cell activation in stable angina pectoris. The American Journal of Cardiology 2002, 89:754-756.
9. Mazzone A., De Servi S., Vezzoli M., et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 1999, 145:369-374.
10. Lemster B.H., Michel J.J., Montag D.T., et al. Induction of CD56 and TCR-Independent activation of T Cells with aging. The Journal of Immunology 2008, 180:1979-1990.
11. Michel J.J., Turesson C., Lemster B., et al. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthritis & Rheumatism 2007, 56:43-57.
12. Koch S., Larbi A., Ozcelik D., et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci. 2007, 1114:23-35.
13. Katchar K., Söderström K., Wahlstrom J., Eklund A., Grunewald J. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. European Respiratory Journal 2005, 26:77-85.
14. Yu H.G., Lee D.S., Seo J.M., et al. The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis. Clinical & Experimental Immunology 2004, 137:437-443.
15. Ahn J.K., Chung H., Lee D.-s., Yu Y.S., Yu H.G. CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behçet's uveitis. The Journal of Immunology 2005, 175:6133-6142.
16. Ahn J.K., Seo J.-M., Yu J., Oh F.S., Chung H., Yu H.G. Down-regulation of IFN-γ-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis. Investigative Ophthalmology & Visual Science 2005, 46:2458-2464.
17. Tarazona R., DelaRosa O., Alonso C., et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mechanisms of Ageing and Development 2000, 121:77-88.
18. Davila E., Kang Y.M., Park Y.W., et al. Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. The Journal of Immunology 2005, 174:7292-7301.
19. Shimamoto M., Ueno Y., Tanaka S., et al. Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis. World Journal of Gastroenterology 2007, 13:5995-6002.
20. Ohkawa T., Seki S., Dobashi H., et al. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology 2001, 103:281-290.
21. Kelly-Rogers J., Madrigal-Estebas L., O'Connor T., Doherty D.G. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Human Immunology 2006, 67:863-873.
22. Romo N., Fitó M., Gumá M., et al. Association of atherosclerosis with expression of the LILRB1 receptor by human NK and T-Cells supports the infectious burden hypothesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2314-2321.
23. Jonasson L., Tompa A., Wikby A. Expansion of peripheral CD8+ T cells in patients with coronary artery disease: relation to cytomegalovirus infection. Journal of Internal Medicine 2003, 254:472-478.
24. Backteman K., Ernerudh J. Biological and methodological variation of lymphocyte subsets in blood of human adults. Journal of Immunological Methods 2007, 322:20-27.
25. Halcox J.P., Deanfield J.E. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation 2004, 109:II42-II48.
26. Correia M.P., Costa A.V., Uhrberg M., Cardoso E.M., Arosa F.A. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology 2011, 216:604-612.
27. Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE 2011, 6. e16103.
28. Spaulding C., Guo W., Effros R.B. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Experimental Gerontology 1999, 34:633-644.
29. Ranjbaran H., Sokol S.I., Gallo A., et al. An inflammatory pathway of IFN-γ production in coronary atherosclerosis. The Journal of Immunology 2007, 178:592-604.
30. Pedersen E.R., Midttun Ø., Ueland P.M., et al. Systemic markers of interferon-ã-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:698-704.
31. Ghittoni R., Lazzerini P.E., Pasini F.L., Baldari C.T. T lymphocytes as Targets of statins: molecular mechanisms and therapeutic perspectives. Inflammation & Allergy - Drug Targets 2007, 6:3-16.